4D Molecular Therapeutics (FDMT) Enterprise Value Growth (1y) (2020 - 2026)
4D Molecular Therapeutics (FDMT) Enterprise Value Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | 4D Molecular Therapeutics | 656.48 Mn | 656.48 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -21.61% |
| Dec 31, 2025 | 5.23% |
| Sep 30, 2025 | 39.22% |
| Jun 30, 2025 | 45.89% |
| Mar 31, 2025 | 38.88% |
| Dec 31, 2024 | -47.41% |
| Sep 30, 2024 | -57.01% |
| Jun 30, 2024 | -74.63% |
| Mar 31, 2024 | -162.36% |
| Dec 31, 2023 | -34.97% |
| Sep 30, 2023 | -40.38% |
| Jun 30, 2023 | -28.73% |
| Mar 31, 2023 | 15.12% |
| Dec 31, 2022 | 13.81% |
| Sep 30, 2022 | -40.85% |
| Jun 30, 2022 | 1.09% |
| Mar 31, 2022 | 9.12% |
| Dec 31, 2021 | 10.46% |
| Dec 31, 2020 | -457.33% |